Rupert D'Souza, Chief Financial Officer at Adverum Biotechnologies, Inc. (ADVM), bought 20,000 shares at $0.83 ($17K) on 2022-05-17, disclosed to the SEC on 2022-05-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Several strong factors at once. The rarest rating we give.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.86 | 10,000 | $9K | 50.9% |
| 2 | $0.83 | 10,000 | $8K | 49.1% |
| Total | $0.84 avg | 20,000 | $17K | 100% |